Acetaldehyde → HCID 73505015、化合物
反応式
[NH2:1][C:2]1[C:6]2[C:7]([CH2:23][O:24][CH3:25])=[N:8][C:9]([NH:11][C:12]([NH:14][C@@H:15]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[CH3:16])=[O:13])=[CH:10][C:5]=2[NH:4][N:3]=1.[O-]S([O-])(=O)=O.[Mg+2].[C:32](O)([C:34](F)(F)F)=O.C(=O)C.C([BH3-])#N.[Na+]>C(Cl)(Cl)Cl.CO>[CH2:32]([NH:1][C:2]1[C:6]2[C:7]([CH2:23][O:24][CH3:25])=[N:8][C:9]([NH:11][C:12]([NH:14][C@@H:15]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[CH3:16])=[O:13])=[CH:10][C:5]=2[NH:4][N:3]=1)[CH3:34]参加物
実験手順
A solution of (R)-1-(3-amino-4-(methoxymethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl)-3-(1-phenylethyl)urea (34.8 mg, 0.102 mmol) in chloroform (0.6 ml) and MeOH (0.3 ml) was charged with MgSO4 (45 mg, 0.374 mmol), TFA (24 μl, 0.312 mmol) and acetaldehyde (0.02 ml, 0.354 mmol). The mixture was stirred at RT for 1 hr, then charged with sodium cyanoborohydride (22 mg, 0.350 mmol) before it was stirred at RT for 1.5 hr. The mixture was filtered to remove insoluble matter, rinsing with MeOH and DCM and concentrated in vacuo. The residue was purified by mass-triggered reverse-phase HPLC to provide (R)-1-(3-(ethylamino)-4-(methoxymethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl)-3-(1-phenylethyl)urea. MS ESI calc'd for C19H25N6O2 [M+H]+ 369. found 369. 1H NMR (ppm, 500 MHz, DMSO-d6) δ 11.64 (s, 1H), 8.96 (s, 1H), 7.33 (m, 4H), 7.23 (m, 1H), 7.15 (s, 1H), 5.56 (t, J=6.5 Hz, 1H), 4.85 (t, J=7.3 Hz), 4.63 (m, 2H), 3.32 (s, 3H, overlaps with H2O peak), 3.22 (m, 2H), 1.39 (d, 6.8 Hz, 3H), 1.20 (t, J=4.9 Hz, 3H).
後処理
- stirringwas stirred at RT for 1.5 hr
- filtrationThe mixture was filtered
- customto remove insoluble matter
- washrinsing with MeOH and DCM
- concentrationconcentrated in vacuo
- customThe residue was purified by mass-triggered reverse-phase HPLC
出典と根拠
- ORDレコード
- ord-91b0ad1d6cb340de9e03937238ad4a15
- 出典データセット
- uspto-grants-2016_01
- 特許番号
- US09233979B2
反応ノート
読み込み中…